|
|
|
- なおみ わたぬき
- 7 years ago
- Views:
Transcription
1
2
3 gtf Wnt5a-Ror2 IL-8 in vitro
4 Ozony Tron P. gingivalis SOD ELISA Location of main occluding areas and masticatory ability in patients with reduced occlusal support
5 12-Methacryloyloxydodecylpyridinium bromide MDPB MDPB PB PB EPMA Streptococcus mutans PB WPB WPB WPB EPMA WPB PB FS WPB PB FS
6 Streptococcus mutans nm WPB MDPB MDPB WPB EPMA WPB Streptococcus mutans WPB
7 Poly P Poly P Ca Poly P Poly P MC3T3-E 1 ALP p-nitrophenyl phosphate substrate, ph10.5 Fluoresceinisothiocyanate FITC annexin V propidium iodide PI flow cytometory FCM total RNA reverse transcriptase-polymerase chain reaction RT-PCR Poly P polyethyleneimine thin layer chromatography PEI-TLC plate MC3T3-E1 Poly P Pi mmol/l MC3T3-E1 mmol/l Poly P ALP MC3T3-E1 mmol/l Poly P FCM Poly P
8 PI annexin V Poly P MC3T3-E1 osteocalcin β- Poly P MC3T3-E1 Poly P PEI-TLC Poly P Poly PPi PPi Pi3 Pi4 MC3T3-E1 β- Poly P Poly P Emdogain p Poly P Poly P Poly P Poly P Poly P Poly P Pi PPi Pi3 Poly P in vivo Poly P Poly P Poly P Poly P MC3T3-E1 in vivo in vitro
9
10 gtf CSI dft CSI dftcsi Real-time PCR S. mutans S.sobrinus gtf gtf gtf B gtf C gtf D
11 gtf I S. mutans gtf B D gtf B D S. sobrinus S. mutans gtf I gtf S. mutans S. sobrinus gtf B gtf C gtf D dft CSI dftcsi Real-time PCR S. mutans S. sobrinus S. mutans gtf B gtf D gtf
12
13 Wnt5a-Ror2 TNFα IL-1 Wnt5a Wnt5a Ror2 Wnt5a RT-PCR D Wnt5a GST-soluble Ror2 GST-sRor2 GST Ror2 Wnt5a Mφ M-CSF RANKL TRAP HE Ror2 Wnt5a GST-sRor2
14 GST Wnt5a Ror2 Mφ Wnt5a Mφ M-CSF RANKL Mφ Wnt5a Ror2 Wnt5a Wnt5a Wnt5a-Ror2 Wnt 5a Ror2 GST-sRor2 GST-sRor2 Wnt Wnt5a Ror2 Wnt5a Ror2 Wnt5a Ror2 RT-PCR Wnt5a Ror2 Ror Ror2 GST-sRor2Wnt5a Wnt5a Ror2 Wn5a-Ror2 Ror2 Wnt5a-Ror2 Wnt
15 Wnt5a Ror2 Ror2 Wnt5a Wnt5a-Ror2
16 IL-8 AZM in vitro AZM IL -8 IL-8 TNF-α AZM AZM in vitro MMP EM AZM JOM Porphyromonas gingivalis LPS ng/ml IL-6 IL-8 PGE ELISA µg/ml IL-6 IL-8 PGE MMP
17 AMZ LPS IL-8 EM JOM LPS IL-8 LPS IL-6 PGE MMP-2 MMP-9 AZM LPS IL-8 ERK JNK p38mapk PKA PI3K PLCγ NF-κB IL-8 NF-κB PGE AZM LPS IL-8 in vitro PGEIL-6 IL-8 AZM LPS IL-8 AZM IL-8 IL-8 IL-6 IL-8 PGE
18 1.8-cineol 1.8-cineol 1.8-cineol mg/ml Candida albicans JCM 1842 Klebsiella pneumoniae JCM 1662 Prevotella intermedia ATCC Prevotella nigrescens ATCC Actinobacillus actinomycetemcomitans JCM 8577 Porphyromonas gingivalis ATCC Streptococcus mutans Ingbritt Streptococcus sobrinus 6715 Streptococcus salivarius JCM cineol 1.8-cineol Streptococcus salivarius
19 1.8-cineol 1.8-cineol 1.8-cineol
20
21 µm
22 R SS SEP g SEP P N P -N µ P -N P -N
23 SEP SEP SEP
24 AIC χ Fisher s exact probability test
25
26 cdna PCR in situ ISH real time PCR myelin basic protein MBP MBP
27 ISH MBP MBP real time PCR myelin basic protein MBP PCR real time PCR in situ
28 in vitro PG EIL-6 IL-8 in vitro Porphyromonas gingivalis LPS ng/ml PGEIL-6 IL-8 ELISA MEK DMSO LPS COX -2 - mg/ml COX COX Inhibitor Screening Assay Kit COX Inhibitor Screening Assay Kit AcPLA ERK ERK LPS COX R http : //
29 LPS PGE LPS PGE LPS IL-6 IL-8 COX-1 COX-2 LPS COX-2 mg/ml LPS cpla ERK cpla MEK LPS PGE MEK LPS IL-6 IL-8 LPS PGE LPS PGE ERK ERK cpla PGE LPS in vitro PGEIL-6 IL-8 ERK cplapge in vitro
30
31 -L-
32 VF VE QOL VE VE VE VF
33 Wallenberg VF
34 BMP in vitro in vivo
35
36 R SS SEP A SEP P - N A A
37 P -N A P -N P -N P -N P -N A P -N P -N A A SEP A
38 A A
39 A Ca bfgf bfgf in vitro Gin-1-1 WST-1 Gin-1 / µm DMSO bfgf ELISA Gin-1 mm bfgf Student t p
40 Gin-1 bfgf in vitro in vitro Gin-1
41 Candida albicans C. albicans JCM1542 MCZ NCCLS MCZ MIC80 MCZ RPMI µg/ml MCZ µl GC mmφmm stroke / CFU/ml C. albicans µl SCDLP C. albicans µg/ml MCZ MCZ MIC -µg/ml RPMI µg/ml
42 MIC MCZ C. albicans µg/ml µg/ml - MCZ MCZ
43 Ozony Tron Ozony Tron Ozony Tron
44 Ozony Tron Ozony Tron
45 P. gingivalis SOD ELISA SOD Porphyromonas gingivalis P. g. SOD SOD Fe-SODMn -SOD P. g. SOD Amano, A J Bacteriol 172 : , 1990 P. gingivalis Fe-SOD Mn-SOD P. g. SOD P. g. SOD ELISA ELISA SOD SOD SOD microtiter plate ELISA P. gingivalis ATCC SOD ELISA SOD
46 pmolnmol P. g. SOD ELISA SOD SOD SOD SOD SOD ELISA SOD P. g. SOD ELISA P. g. SOD ELISA ELISA P. g. SOD pmolnmol P. g. SOD ELISA ELAISA P. gingivalis SOD SOD SOD ELISA SOD P. gingivalis P. g. SOD ELISA SOD P. gingivalis SOD P. gingivalis P. g. SOD ELISA SOD
47 Cambialistic SOD Fe Mn SOD P. g. SOD P. gingivalis P. gingivalis SOD
48 Location of main occluding areas and masticatory ability in patients with reduced occlusal support Eichner A1 Eichner B1 B4 C1 C3 mm PM M Eichner
49 Eichner A1 Eichner B C Eichner C1 Eichner Chi square test ; p Eichner A1 B1 C3 Eichner one-factor ANOVA ; p PM M Student t-test ; p Eichner
µ µ µ µ
Title 東 京 歯 科 大 学 研 究 年 報 : 平 成 15 年 度 Journal 東 京 歯 科 大 学 研 究 年 報, (): - URL http://hdl.handle.net/10130/388 Right Posted at the Institutional Resources for Unique Colle Available from http://ir.tdc.ac.jp/
nsg02-13/ky045059301600033210
φ φ φ φ κ κ α α μ μ α α μ χ et al Neurosci. Res. Trpv J Physiol μ μ α α α β in vivo β β β β β β β β in vitro β γ μ δ μδ δ δ α θ α θ α In Biomechanics at Micro- and Nanoscale Levels, Volume I W W v W
第86回日本感染症学会総会学術集会後抄録(I)
κ κ κ κ κ κ μ μ β β β γ α α β β γ α β α α α γ α β β γ μ β β μ μ α ββ β β β β β β β β β β β β β β β β β β γ β μ μ μ μμ μ μ μ μ β β μ μ μ μ μ μ μ μ μ μ μ μ μ μ β
_0212_68<5A66><4EBA><79D1>_<6821><4E86><FF08><30C8><30F3><30DC><306A><3057><FF09>.pdf
研修コーナー
l l l l l l l l l l l α α β l µ l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l
プログラム
12 Porphyromonas gingivalis Porphyromonas gingivalis Porphyromonas gingivalis Porphyromonas gingivalis Porphyromonas gingivalis Porphyromonas gingivalis 13 14 Porphyromonas gingivalis fima fi ma Porphyromonas
nsg04-28/ky208684356100043077
δ!!! μ μ μ γ UBE3A Ube3a Ube3a δ !!!! α α α α α α α α α α μ μ α β α β β !!!!!!!! μ! Suncus murinus μ Ω! π μ Ω in vivo! μ μ μ!!! ! in situ! in vivo δ δ !!!!!!!!!! ! in vivo Orexin-Arch Orexin-Arch !!
50mg 75mg (1) H 3 C O OH HO H O O H OH SO H 3 Na H H N H 2 N NH OH H N O O H H O OH H 3 C H O O N H H H HO H NH CH 3 HN HO H OH O H OH H NH
3240 14 8 8 50mg 75mg 13 6 25 1-(1) H 3 C O OH HO H O O H OH SO H 3 Na H H N H 2 N NH OH H N O O H H O OH H 3 C H O O N H H H HO H NH CH 3 HN HO H OH O H OH H NH O N O C 56 H 70 N 9 NaO 23 S 1292.26 5-[(1S,2S)-2-
1 911 9001030 9:00 A B C D E F G H I J K L M 1A0900 1B0900 1C0900 1D0900 1E0900 1F0900 1G0900 1H0900 1I0900 1J0900 1K0900 1L0900 1M0900 9:15 1A0915 1B0915 1C0915 1D0915 1E0915 1F0915 1G0915 1H0915 1I0915
O1-1 O1-2 O1-3 O1-4 O1-5 O1-6
O1-1 O1-2 O1-3 O1-4 O1-5 O1-6 O1-7 O1-8 O1-9 O1-10 O1-11 O1-12 O1-13 O1-14 O1-15 O1-16 O1-17 O1-18 O1-19 O1-20 O1-21 O1-22 O1-23 O1-24 O1-25 O1-26 O1-27 O1-28 O1-29 O1-30 O1-31 O1-32 O1-33 O1-34 O1-35
< B C957491E48E86312E696E6464>
10 DDS New York Academy Renal Biochemistry (Elsevier) Glutathione (John Wiley & Sons) Antioxidants in Therapy and Preventive Medicine (Plenum) The Liver: Biology and Pathophysiology (Raven Press) NO SSC
N cos s s cos ψ e e e e 3 3 e e 3 e 3 e
3 3 5 5 5 3 3 7 5 33 5 33 9 5 8 > e > f U f U u u > u ue u e u ue u ue u e u e u u e u u e u N cos s s cos ψ e e e e 3 3 e e 3 e 3 e 3 > A A > A E A f A A f A [ ] f A A e > > A e[ ] > f A E A < < f ; >
- 1 -
- 1 - - 1 - ... 1... 2... 4... 5... 9... 11... 14... 16... 20... 21... 22... 23... 23 - 1 - - 2 - - 3 - - 4 - - 5 - - 6 - - 7 - - 8 - - 9 - ( ) - 10 - - 11 - Pseudomonas aeruginosa Escherichia coli Staphylococcus
n 2 + π2 6 x [10 n x] x = lim n 10 n n 10 k x 1.1. a 1, a 2,, a n, (a n ) n=1 {a n } n=1 1.2 ( ). {a n } n=1 Q ε > 0 N N m, n N a m
1 1 1 + 1 4 + + 1 n 2 + π2 6 x [10 n x] x = lim n 10 n n 10 k x 1.1. a 1, a 2,, a n, (a n ) n=1 {a n } n=1 1.2 ( ). {a n } n=1 Q ε > 0 N N m, n N a m a n < ε 1 1. ε = 10 1 N m, n N a m a n < ε = 10 1 N
›Ê”÷„¤‰ƒ‘−…j…–†[…X
ISSN 1347-0345 National Institute of Fruit Tree Science 2003. 10 2 2003. 10 3 19761986 1989 5219 1997 19 12 10 250 270g Brix 15 160.5g/100ml 1590 10 2003. 10 4 DNA DNASSR 44 41SSR SSR Simple Sequence Repeat=
第14〜15回 T細胞を介する免疫系.pptx
MBL CD8 CD4 8.1 8.2 5.20 8.3 8.4 8.5 8.6 8.7 8.8 8.9 8.10 8.18 B7 CD28 CD28 B7 CD28 8.13 2.22 NK Toll(TLR) LBP! LPS dsrna ssrna TLR1/2/6! TLR4 TLR5 TLR3 TLR7/9 CD14! JNK/p38! MyD88! IRAK! TRAF! NFκB! TNF-α
ver5.1 HS 1. ALPHA LIPOIC ACID () S S COOH HS 1. α - SH COOH - ( 1) CoA -( 2)- - --P80 (--WSP8-L1-WSPC8 -LC1) - 1
ORYZA OIL & FAT CHEMICAL CO., LTD. ALPHA LIPOIC ACID --P () --P80 () --WSP8 () --L1 () --PC () --PC80 () --WSPC8 () --LC1 () ver. 5.1HS ver5.1 HS 1. ALPHA LIPOIC ACID 16 3 31 0331009 - () 19 5 24 0524001
AS LMD Sampling Manual
AS LMD Application Solutions LaserMicrodissection System LMD SamplingManual 2005 1 AS LMD Sampling Manual -------------------------------------------------------------2 --------------------------------------
日本化学療法学会雑誌第58巻第2号
Key words β Candida Table1. MCFGCPAstudygroup Investigator (representative) YoshitsuguMiyazaki NaoyukiMiyashita RyoichiAmitani KenjiOgawa AtsuyukiKurashima ToshiroKiguchi MichiakiMishima YuichiInoue HiroshiSaito
研究目的 1. 電波ばく露による免疫細胞への影響に関する研究 我々の体には 恒常性を保つために 生体内に侵入した異物を生体外に排除する 免疫と呼ばれる防御システムが存在する 免疫力の低下は感染を引き起こしやすくなり 健康を損ないやすくなる そこで 2 10W/kgのSARで電波ばく露を行い 免疫細胞
資料 - 生電 6-3 免疫細胞及び神経膠細胞を対象としたマイクロ波照射影響に関する実験評価 京都大学首都大学東京 宮越順二 成田英二郎 櫻井智徳多氣昌生 鈴木敏久 日 : 平成 23 年 7 月 22 日 ( 金 ) 場所 : 総務省第 1 特別会議室 研究目的 1. 電波ばく露による免疫細胞への影響に関する研究 我々の体には 恒常性を保つために 生体内に侵入した異物を生体外に排除する 免疫と呼ばれる防御システムが存在する
5 CSF 6 CSF 7 CSF CSF CDV CDV GFAP CSF Pandy test NSE MBP LDH mu/ml 0-5 /µl AST mu/ml CK mu/ml <25 mg/dl<45 mg/dl GLU
CT MRI CSFCSF CSF CSF CSF CSF CSF (cisternal puncture) CSF 20-23G 90 (20-23G) : CSF
2.7 臨床概要
2.7 臨床概要 A/G Al-P ALT AST AT- AUC AZM BIPM BP BUN CEZ CFPN-PI CFU CLcr Cmax CNS COPD CPFX CRP CS CYP CVA DBT DHP-I DIC DRPM DRPM-DC FAS γ-gtp GCP GNB GNF-GNR GPB HAM - Staphylococcus C P450 -I Full Analysis
日本化学療法学会雑誌第56巻第1号
β β β β β Streptococcus pneumoniaehaemophilus influenzaemoraxella catarrhalismycoplasma pneumoniaechlamydia pneumoniae β Key wordsβ mys nilc laci ngis Table. Assessmentschedule Parameters Patientcharacteristics
取扱説明書 [F-05E]
F-05E 12.11 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 a b 22 c d e 23 24 a o c d a b p q b o r s e f h i j k l m g f n a b c d e f g h 25 i j k l m n o p q r s a X b SD 26 27 28 X 29 a b c
スライド 1
平成 29 年 6 月 1 日研究成果発表 広島大学大学院 医歯薬保健学研究院 二川浩樹 虫歯 歯周病を抑える L8020 乳酸菌を利用 産学連携で新しいタブレットが誕生 2010 年 10 月 歯磨きしなくても虫歯にならない 昭和 47 年 6 月 29 日生まれ 30 歳 女性 FJ 病院 むし歯の治療歴のない FJ さん 昭和 47 年 6 月 29 日生まれ,30 歳, 女性の口腔内写真 必ずしも口腔内衛生状態は良いわけではない
Microsoft Word - web.docx
12 10 E 16:30 17:30 : ( ) " " ( ) 12 10 15:50 16:20 A 1 ( ) ( ) B ( ) ( ) D ( ) ( 12 11 B 10:00 12:00 " " ( ) ( ) 2 (10 ) A 1 ( ) 8:30 12:40 8:30 9:20 1 ( ) 1A-01 Cannabidiol-2',6'-dimethyl ether ( 1,
MUFFIN3
MUFFIN - MUltiFarious FIeld simulator for Non-equilibrium system - ( ) MUFFIN WG3 - - JCII, - ( ) - ( ) - ( ) - (JSR) - - MUFFIN sec -3 msec -6 sec GOURMET SUSHI MUFFIN -9 nsec PASTA -1 psec -15 fsec COGNAC
2009 SEP. No.664 9 18 100460345 209710798 %0.11 3350955 9750799 12.1 0.93 100350 19 100600453 209700800 %0.03 3200065 9740873 11.0 0.98 90490 20 100750364 209680396 %0.81 321 844 978 591 11.6
untitled
PCRM-PCR PCR MPCR Dualreal PCR PCR (M-PCR) PCR (M-PCR) Q & A PCR DNA 50 2030 DNA PCR 1 PCR (MPCR) MBI PCR 1 MPCR 1 MPCR DNA 1 PCR 510 DNA (US patent 5, 582, 989) 1 DNA ( 1) MPCR GC MBI MPCR PCR DNA 2 MBI
ROWCatPathology_J.book
www.dako.jp IHC Solution Visualization Systems Number of Steps 5 4 3 2 1 LSAB TM 2 EnVision TM G 2 Doublestain EnVision TM DuoFLEX Doublestain LSAB TM + EnVision TM G 2 EnVision TM + EnVision TM FLEX 1
研究成果報告書(基金分)
DNA cdna mrna DNA ( /) (PS) (PS-tag: RIIIRRIRR) PS scfv PS-tag PS-tag scfv (PMMA)(PC) -S- (GST)PC PMMA GST GST PMMA-tag: DVEGIGDVDLVNYFEVGAT- YTFNK PC-tag: NSNFFGLVDGLNF- AVQYLGK) -S- PS-tag PMMA-tagPC-tag
ッ ー ー ー() () 2.5 () () 21 1) -1 2) -2 10 m 5 7 23 6 1)2) 3) -1-2 H23.4.25 -15-20 4 75 5 1) -1 (5) (3) (3) (2) (1) (1) (1) (1) (1) (1) (1) (1) (1) (1) (1) (1) 1) ( 23 6 8 ) 2) 22 3)
(2009) 1... / 1 ( ) / 1 ( ) / 1 ( ), 2 ( )
212009................................................ 2............................................ 115 (2009) 1... / 1 ( )........................................... 4 2... / 1 ( )......................................
1.500 m X Y m m m m m m m m m m m m N/ N/ ( ) qa N/ N/ 2 2
1.500 m X Y 0.200 m 0.200 m 0.200 m 0.200 m 0.200 m 0.000 m 1.200 m m 0.150 m 0.150 m m m 2 24.5 N/ 3 18.0 N/ 3 30.0 0.60 ( ) qa 50.79 N/ 2 0.0 N/ 2 20.000 20.000 15.000 15.000 X(m) Y(m) (kn/m 2 ) 10.000
untitled
PCR Enzymes & Instruments PCR Stratagene Gradient Cycler Problem PCRDNA Polymerase Solution Stratagene Gradient Cycler PCRQuikChange 3 Stratagene Gradient Cycler 96 96 Fast 384 3 3 0.4 0.1 12 96 Fast 384
3 1 2
Agilent 4200 TapeStation Agilent 4200 TapeStation 3 1 2 2 3 ScreenTape 3 Agilent 4200 TapeStation QC Agilent 4200 TapeStation Ready-to-use ScreenTape 8 PCR 96-well plate 1 96 1 qrt-pcr DNA RNA DNA / RNA
PowerPoint プレゼンテーション
0 1 2 3 4 5 6 1964 1978 7 0.0015+0.013 8 1 π 2 2 2 1 2 2 ( r 1 + r3 ) + π ( r2 + r3 ) 2 = +1,2100 9 10 11 1.9m 3 0.64m 3 12 13 14 15 16 17 () 0.095% 0.019% 1.29% (0.348%) 0.024% 0.0048% 0.32% (0.0864%)
2 1 7 - TALK ABOUT 21 μ TALK ABOUT 21 Ag As Se 2. 2. 2. Ag As Se 1 2 3 4 5 6 7 8 9 1 1 2 3 4 5 6 7 8 9 1 1 2 3 4 5 6 7 8 9 1 Sb Ga Te 2. Sb 2. Ga 2. Te 1 2 3 4 5 6 7 8 9 1 1 2 3 4 5 6 7 8 9 1 1 2 3 4
xxxxEN.qxd
Ultron ES-VM : HPLC HPLC 28,000, 1-120Å 5-µm Ultron ES-VM [1-] Ultron ES-VM HPLC ph pi 3.8 4.3 Ultron ES-VM ph pi ph pka = 4.4 ph 3.0 6.0 pka = 4.0 9.2 k' 1 αph 1 Ibuprofen H3 C CHCH 2 CH CH H 3 C Chlorpheniramine
エピトープタグ抗体製品リスト PM020 Anti-DDDDK-tag pab Polyclonal Rabbit Ig (aff.) WB, IP, IC 100 ml 15,000 PM020-7 Anti-DDDDK-tag pab HRP-DirecT Polyclonal Rabbit I
(kda) 150 100 DDDDK-tagged protein 75 50 37 IgG Heavy chain 25 20 IgG Light chain Sample: N-terminal DDDDK-tagged β-gal protein transfectant μ μ μ http://ruo.mbl.co.jp/ エピトープタグ抗体製品リスト PM020 Anti-DDDDK-tag
- 1 - 2 ç 21,464 5.1% 7,743 112 11,260 2,349 36.1% 0.5% 52.5% 10.9% 1,039 0.2% 0 1 84 954 0.0% 0.1% 8.1% 91.8% 2,829 0.7% 1,274 1,035 496 24 45.0% 36.6% 17.5% 0.8% 24,886 5.9% 9,661 717 6,350 8,203 38.8%
